These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35530903)

  • 41. Systemic Pseudohypoaldosteronism Type I: A Case Report and Review of the Literature.
    Nur N; Lang C; Hodax JK; Quintos JB
    Case Rep Pediatr; 2017; 2017():7939854. PubMed ID: 28484659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pseudohypoaldosteronism type 1: clinical features and management in infancy.
    Amin N; Alvi NS; Barth JH; Field HP; Finlay E; Tyerman K; Frazer S; Savill G; Wright NP; Makaya T; Mushtaq T
    Endocrinol Diabetes Metab Case Rep; 2013; 2013():130010. PubMed ID: 24616761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects.
    Hanukoglu A
    J Clin Endocrinol Metab; 1991 Nov; 73(5):936-44. PubMed ID: 1939532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Unique Genotype of Pseudohypoaldosteronism Type 1b in a Highly Consanguineous Population.
    Alzahrani AS; Alswailem M; Abbas BB; Qasem E; Alsagheir A; Al Shidhani A; Al Sinani A; Al Badi M; Al-Maqbali A; Al Shawi M; Albunyan A; Bin Nafisah A; Shi Y
    J Endocr Soc; 2021 Aug; 5(8):bvab095. PubMed ID: 34258491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two Japanese patients with the renal form of pseudohypoaldosteronism type 1 caused by mutations of NR3C2.
    Morikawa S; Komatsu N; Sakata S; Nakamura-Utsunomiya A; Okada S; Tajima T
    Clin Pediatr Endocrinol; 2015 Jul; 24(3):135-8. PubMed ID: 26594094
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exclusion of the locus for autosomal recessive pseudohypoaldosteronism type 1 from the mineralocorticoid receptor gene region on human chromosome 4q by linkage analysis.
    Chung E; Hanukoglu A; Rees M; Thompson R; Dillon M; Hanukoglu I; Bistritzer T; Kuhnle U; Seckl J; Gardiner RM
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3341-5. PubMed ID: 7593448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel mutation of the epithelial Na+ channel causes type 1 pseudohypoaldosteronism.
    Bonny O; Knoers N; Monnens L; Rossier BC
    Pediatr Nephrol; 2002 Oct; 17(10):804-8. PubMed ID: 12376807
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pseudohypoaldosteronism in infants with salt wasting syndrome. Two case reports].
    Szalecki M; Wójcik E; Domagała Z; Małunowicz E
    Pediatr Endocrinol Diabetes Metab; 2007; 13(1):33-6. PubMed ID: 17493404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ocular and skin manifestations in systemic pseudohypoaldosteronism.
    Eliwa MS; El-Emmawie AH; Saeed MA
    BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24654255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pseudohypoaldosteronism.
    Riepe FG
    Endocr Dev; 2013; 24():86-95. PubMed ID: 23392097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1.
    Riepe FG; Finkeldei J; de Sanctis L; Einaudi S; Testa A; Karges B; Peter M; Viemann M; Grötzinger J; Sippell WG; Fejes-Toth G; Krone N
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4552-61. PubMed ID: 16954160
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pseudohypoaldosteronism type-I: a rare cause of hyperkalemia in neonates.
    Bangash AS; Ali NF; Sami S; Iqbal M
    J Pak Med Assoc; 2014 Apr; 64(4):484-6. PubMed ID: 24864655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and molecular analysis of six Japanese patients with a renal form of pseudohypoaldosteronism type 1.
    Hatta Y; Nakamura A; Hara S; Kamijo T; Iwata J; Hamajima T; Abe M; Okada M; Ushio M; Tsuyuki K; Tajima T
    Endocr J; 2013; 60(3):299-304. PubMed ID: 23197115
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mineralocorticoid resistance.
    Zennaro MC; Lombès M
    Trends Endocrinol Metab; 2004 Aug; 15(6):264-70. PubMed ID: 15358279
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Salt wasting disorder in the newborn.
    Ranjith G; Uthup S; Satish B; Jain N
    Indian J Pediatr; 2006 Jan; 73(1):95-6. PubMed ID: 16444070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mineralocorticoid receptor mutations and a severe recessive pseudohypoaldosteronism type 1.
    Hubert EL; Teissier R; Fernandes-Rosa FL; Fay M; Rafestin-Oblin ME; Jeunemaitre X; Metz C; Escoubet B; Zennaro MC
    J Am Soc Nephrol; 2011 Nov; 22(11):1997-2003. PubMed ID: 21903996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac arrest in a newborn: A case of pseudohypoaldosteronism.
    Tauber KA; Ermacor K; Listman J
    Clin Case Rep; 2024 Feb; 12(2):e8265. PubMed ID: 38344358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rare Cause of Hyperkalemia in the Newborn Period: Report of Two Cases of Pseudohypoaldosteronism Type 1.
    Manipriya R; Umamaheswari B; Prakash A; Binu N
    Indian J Nephrol; 2018; 28(1):69-72. PubMed ID: 29515305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fetal pseudohypoaldosteronism: another cause of hydramnios.
    Greenberg D; Abramson O; Phillip M
    Acta Paediatr; 1995 May; 84(5):582-4. PubMed ID: 7633160
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel mutations in epithelial sodium channel (ENaC) subunit genes and phenotypic expression of multisystem pseudohypoaldosteronism.
    Edelheit O; Hanukoglu I; Gizewska M; Kandemir N; Tenenbaum-Rakover Y; Yurdakök M; Zajaczek S; Hanukoglu A
    Clin Endocrinol (Oxf); 2005 May; 62(5):547-53. PubMed ID: 15853823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.